Uzma A. Syeda, MD
NPI 1174562565ActiveIndividual· Internal Medicine, Rheumatology· Grapevine, TX
Internal Medicine, Rheumatology (MD) with Grapevine Rheumatology Clinic,llc, practicing in Grapevine, Texas. Their prescriptions cost Medicare Part D more than their services did: $1,500,110 for 3,308 claims, against $828,777 paid for services in 2024. Ucb, Inc. was the largest of 16 companies reporting payments in 2025, $2,103 in all, mostly food and beverage.
Overview
| NPI | 1174562565 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jun 4, 2006 |
| Last updated in NPPES | Mar 28, 2023 |
| Certified by provider | Mar 28, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | P2540 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Rheumatology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 377 |
|---|---|
| Services billed | 98,900 across 32 procedure codes |
| Paid by Medicare | $828,777 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,308 · 4,931 30-day fills |
|---|---|
| Patients | 436 |
| Total drug cost | $1,500,110 |
| Generic share | 89% of claims |
Education and affiliations
| Graduation year | 1998 |
|---|---|
| Medicare specialty | Rheumatology |
| Telehealth | Offers telehealth |
Medical group
- Grapevine Rheumatology Clinic,llcGrapevine, TX · 2 clinicians
Industry payments (Open Payments)
- 2025$2,103 · 84 payments from 16 companies
- 2024$1,518 · 64 payments from 14 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Ucb, Inc. | $350.61 | 9 |
| Amgen Inc. | $349.07 | 23 |
| Janssen Biotech, Inc. | $348.90 | 10 |
| Glaxosmithkline, LLC. | $247.19 | 7 |
| Abbvie Inc. | $229.74 | 10 |
What the 2025 payments were for
- Food and Beverage$2,103 · 84 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records